BAMF
MNTA

BI Asset Management Fondsmaeglerselskab’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-41,023
Closed -$1.12M – 470
2020
Q1 		$1.12M Buy
+41,023
New +$1.14M 0.07% 231

Other funds holding MNTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's MNTA Position: Q2 2020 in Review

BI Asset Management Fondsmaeglerselskab sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2020, closing a stake of 41,023 shares — an estimated $1.12M sold.

BI Asset Management Fondsmaeglerselskab first reported a position in MNTA in Q1 2020 and held it in 1 quarter. The position peaked at $1.12M in Q1 2020. 237 funds tracked by Wall St. Rank hold MNTA as of Q2 2020.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 41,023 Momenta Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1.12M.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2020 and held it in 1 quarter.
  • BI Asset Management Fondsmaeglerselskab's Momenta Pharmaceuticals, Inc. position peaked at $1.12M in Q1 2020.
  • 237 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2020.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2020, filed 5 Aug 2020.